Orbit Exports Limited (ORBTEXP) Stock Analysis | TradeAlone

ANTHEM2 months ago

Anthem Biosciences Limited (NSE: Anthem) Investor Presentation July 21, 2026: Strong Business Performance and Robust Margins

Anthem Biosciences Limited (NSE: ANTHEM) investor presentation highlights strong Q1FY27 performance with robust margins and promising future outlook.
ANTHEM5 months ago

Anthem Biosciences Limited (NSE: Anthem) Q4 FY26: Revenue Up 26%, PAT Surges 130%

Anthem Biosciences Limited (NSE: ANTHEM) announced its Q4 FY26 results with a 26% YoY revenue growth and a 129.8% surge in PAT.

More Posts

Exit mobile version